Literature DB >> 17520234

[Early evaluation of neurological prognosis and therapy after cardiopulmonary resuscitation: current opportunities and clinical implications].

A Ragoschke-Schumm1, R Pfeifer, G Marx, N Knoepffler, O W Witte, S Isenmann.   

Abstract

The developments of cardiopulmonary resuscitation and intensive care medicine have made possible survival after cardiac arrest. However, only 10-30% of patients with initially successful resuscitation later reach a state without severe neurological impairment. Ethical and socioeconomic reasons therefore make early prognosis important for certain patients. There are no reliable parameters for predictions of good clinical outcome. If clinical information is consistent with severe hypoxic brain damage, cortical somatosensory evoked potentials are absent, and neuron-specific enolase values exceed 33-65 microg/l, recovery of consciousness can be excluded. The same result can be predicted if brain imaging shows severe hypoxemic changes or if a myoclonic status occurs on the first day. In summary, the prognosis in patients with cerebral anoxy and cardiopulmonary resuscitation remains poor. Treatment with hypothermia for 24 h is recommended.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520234     DOI: 10.1007/s00115-007-2286-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  40 in total

1.  Use of automated external defibrillators by a U.S. airline.

Authors:  R L Page; J A Joglar; R C Kowal; J D Zagrodzky; L L Nelson; K Ramaswamy; S J Barbera; M H Hamdan; D K McKenas
Journal:  N Engl J Med       Date:  2000-10-26       Impact factor: 91.245

Review 2.  Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  E F M Wijdicks; A Hijdra; G B Young; C L Bassetti; S Wiebe
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

3.  Cerebrospinal fluid creatine kinase BB isoenzyme activity and neurologic prognosis after cardiac arrest.

Authors:  D L Tirschwell; W T Longstreth; M E Rauch-Matthews; W L Chandler; T Rothstein; L Wray; L J Eng; J Fine; M K Copass
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

4.  Cerebrospinal fluid creatine kinase isoenzyme BB levels do not predict the clinical outcome in patients unconscious following cardiac resuscitation.

Authors:  P Clemmensen; S Strandgaard; S Rasmussen; P Grande
Journal:  Clin Cardiol       Date:  1987-04       Impact factor: 2.882

5.  Nimodipine after resuscitation from out-of-hospital ventricular fibrillation. A placebo-controlled, double-blind, randomized trial.

Authors:  R O Roine; M Kaste; A Kinnunen; P Nikki; S Sarna; S Kajaste
Journal:  JAMA       Date:  1990-12-26       Impact factor: 56.272

6.  Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia.

Authors:  Marjaana Tiainen; Risto O Roine; Ville Pettilä; Olli Takkunen
Journal:  Stroke       Date:  2003-11-20       Impact factor: 7.914

7.  Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis.

Authors:  R O Roine; H Somer; M Kaste; L Viinikka; S L Karonen
Journal:  Arch Neurol       Date:  1989-07

8.  Public use of automated external defibrillators.

Authors:  Sherry L Caffrey; Paula J Willoughby; Paul E Pepe; Lance B Becker
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

9.  Assessment of neurological prognosis in comatose survivors of cardiac arrest. BRCT I Study Group.

Authors:  E Edgren; U Hedstrand; S Kelsey; K Sutton-Tyrrell; P Safar
Journal:  Lancet       Date:  1994-04-30       Impact factor: 79.321

10.  Prediction of outcome in patients with anoxic coma: a clinical and electrophysiologic study.

Authors:  R Chen; C F Bolton; B Young
Journal:  Crit Care Med       Date:  1996-04       Impact factor: 7.598

View more
  1 in total

1.  Bone marrow-derived mesenchymal stem cell transplantation attenuates overexpression of inflammatory mediators in rat brain after cardiopulmonary resuscitation.

Authors:  Qing-Ming Lin; Xia-Hong Tang; Shi-Rong Lin; Ben-Dun Chen; Feng Chen
Journal:  Neural Regen Res       Date:  2020-02       Impact factor: 5.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.